BYSI - CIK 0001677940
BeyondSpring Inc. trades as BYSI. In its fiscal 2025 annual report the company posted revenue of $0.00 and net income of -$1.01M. This page tracks BeyondSpring Inc. through 245 SEC filings, with financial statements and metrics updated as new reports are filed.
Net profit margin expanded from -33873.9% to -2463.3% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-15 |
| SCHEDULE 13G/A | - | 2026-05-15 |
| Quarterly report | 10-Q | 2026-05-13 |
| Major company event | 8-K | 2026-05-13 |
| Insider trade | 4 | 2026-04-08 |
| Insider trade | 4 | 2026-04-03 |
| Insider trade | 4 | 2026-04-03 |
| Insider trade | 4 | 2026-04-03 |
The largest companies sharing BeyondSpring Inc.'s SEC industry classification (pharmaceutical preparations).
BeyondSpring Inc. reported revenue of $0.00 for fiscal year 2025.
In its latest fiscal year BeyondSpring Inc. reported a net loss of $1.01M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.